Clinical Trial Update: Metformin for Abdominal Aortic Aneurysm Growth Inhibition [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating metformin for inhibiting growth of abdominal aortic aneurysm is ongoing or pending results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Uppsala University Hospital | Conditions: Abdominal Aortic Aneurysm | Phase 2 | Status: UNKNOWN